Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
tFrJcUYNqJEYPrrr
